Complete response and prolonged disease-free survival in a patient with recurrent duodenal adenocarcinoma treated with bevacizumab plus FOLFOX6

Journal of Gastrointestinal Oncology

Gayathri Nagaraj¹  enjamin R. Tan Jr¹  Karin Flora¹  Yousef Zarbalian¹ 

[1] Division of Medical Oncology, Washington University School of Medicine, 660 South Euclid Avenue St. Louis Missouri 63110, USADivision of Medical Oncology, Washington University School of Medicine, 660 South Euclid Avenue St. Louis Missouri 63110, USADivision of Medical Oncology, Washington University School of Medicine, 660 South Euclid Avenue St. Louis Missouri 63110, USA

关键词: Small bowel adenocarcinoma;    bevacizumab;    oxaliplatin;    capecitabine;   

DOI  :  10.3978/j.issn.2078-6891.2013.038

学科分类：肿瘤学

来源: Pioneer Bioscience Publishing Company

【 授权许可】

Unknown